Pluristem Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pluristem Therapeutics

PSTI 8.720

+0.2%

Aug 14 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: xcentral1	2/3/2011 8:48:45 AM
	of 295

Pluristem Therapeutics' Dr. William Prather Interviewed on CorporateProfile.com Marketwire Posted 1:25 PM 02/01/11 Corporate Profile, LLC announced today that Pluristem Therapeutics, Inc. (NASDAQ: PSTI) VP of Corporate Development, Dr. William Prather, was interviewed on CorporateProfile.com. The video can be viewed at: www.corporateprofile.com. Actually : corporateprofile.com About Pluristem Therapeutics Inc.: Pluristem Therapeutics is a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. For more information visit the company website at pluristem.com About Corporate Profile.com CorporateProfile.com is a broadcasting website where Fashion meets Finance. Merging two mainstream industries results in the unique platform for investors to receive today's hottest tips and market info. See full article from DailyFinance: srph.it

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next